SMA
GILD icon

Seven Mile Advisory’s Gilead Sciences GILD Stock Holding History

Seven Mile Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Sell
2,749
-303
-10% -$39.9K 0.23% 95
2026
Q1 		$425K Sell
3,052
-1,535
-33% -$215K 0.31% 69
2025
Q4 		$563K Sell
4,587
-571
-11% -$69.4K 0.1% 104
2025
Q3 		$573K Buy
5,158
+2,060
+66% +$234K 0.09% 114
2025
Q2 		$343K Buy
3,098
+344
+12% +$36.6K 0.21% 101
2025
Q1 		$309K Buy
2,754
+86
+3% +$8.87K 0.21% 108
2024
Q4 		$246K Buy
+2,668
New +$240K 0.16% 124
2023
Q4 		– Sell
-2,941
Closed -$220K – 154
2023
Q3 		$220K Buy
+2,941
New +$226K 0.23% 101

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Seven Mile Advisory's GILD Position: Q2 2026 in Review

Seven Mile Advisory reduced its Gilead Sciences (GILD) stake by 9.9% in Q2 2026, selling an estimated $39.9K and leaving 2,749 shares worth $347K. The position accounts for 0.23% of the portfolio, ranked #95.

Seven Mile Advisory first reported a position in GILD in Q3 2023 and has held it in 8 quarters since. The position peaked at $573K in Q3 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Seven Mile Advisory held 2,749 shares of Gilead Sciences worth $347K as of Q2 2026.
  • Seven Mile Advisory sold 303 Gilead Sciences shares in Q2 2026, an estimated $39.9K.
  • Gilead Sciences made up 0.23% of Seven Mile Advisory's portfolio in Q2 2026, its #95 holding.
  • Seven Mile Advisory first reported a position in Gilead Sciences in Q3 2023 and has held it in 8 quarters since.
  • Seven Mile Advisory's Gilead Sciences position peaked at $573K in Q3 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.